XPhyto Therapeutics Corporation
  • About Us
    • About Us
    • Our Team
  • Our Products
    • Point-of-Care Diagnostics
    • Drug Delivery
    • Psychedelics
  • News
  • Investors
  • Contact
XPhyto Lab Worker with protective eyewear
  • Home
  • News

Category: Press Releases

View all Posts

Show All Press Releases Diagnostics Psychedelics Drug Delivery

Drug Delivery, Press Releases

XPhyto Epilepsy clinical trial planned in 2022 with its proprietary fast-dissolving CBD oral strips

Dec 15, 2021

Vancouver, Canada, and Uttenweiler, Germany (December 15, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...

Continue Reading

Press Releases

XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH

Dec 6, 2021

The acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technologyThe acquisition of 3a, a German-based rapid point-of-care...

Continue Reading

Press Releases

XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000

Nov 29, 2021

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC – November 26, 2021 ‐ XPhyto Therapeutics Corp. (“XPhyto”...

Continue Reading

Press Releases

XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development

Nov 3, 2021

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, and Uttenweiler, Germany (November 3, 2021) -...

Continue Reading

Drug Delivery, Press Releases

XPhyto Reports Development Update for its Drug Delivery Business

Oct 12, 2021

Rotigotine transdermal skin patch optimization and pivotal study planning underwayRotigotine patch manufacturing, sales and marketing in preparationCannabinoid oral dissolvable film (ODF) programs advanced, CBD ODF...

Continue Reading

Diagnostics, Press Releases

XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab

Sep 8, 2021

Vancouver, Canada, and Frankfurt, Germany (September 08, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...

Continue Reading

Press Releases

XPhyto Launches First Commercial Biosensor for Oral Disease

Aug 30, 2021

Biosensor test dissolves on the tongue and turns bitter indicating the presence of oral inflammation after five minutesEasy and simple at-home self-checks improve oral health...

Continue Reading

Diagnostics, Press Releases

XPhyto’s acquisition target, 3a-diagnostics, reports breakthrough identification of COVID-19 biosensor candidates

Jul 28, 2021

First saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto’s oral dissolvable delivery platformBiosensor candidates are ready for optimization and performance assessmentDevelopment of...

Continue Reading

Diagnostics, Press Releases

XPhyto signs transformative acquisition agreement with 3a-diagnostics, to enter hi-tech biosensor market and expand its diagnostic product portfolio

Jul 20, 2021

The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products.The acquisition secures...

Continue Reading

Diagnostics, Press Releases

XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test

Jun 30, 2021

XPhyto signs master supply agreement with operator of 10 COVID-19 test centersThe test will be offered to customers as a rapid PCR test with sample...

Continue Reading

Press Releases, Psychedelics

XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies

Jun 8, 2021

Research and development lab set up, preliminary mescaline synthesis completeModified synthesis process developed, mescaline batches manufacturedDevelopment of analytical methods and validation, GMP standard operating procedures...

Continue Reading

Featured, Press Releases

XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany

May 20, 2021

Rapid 25-minute point-of-care COVID-19 PCR test available for purchase in Germany commencing May 25, 2021Volume based pricing competitive with other COVID-19 PCR test products on...

Continue Reading
Page 2 of 71234567
Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.

  • About Xphyto
  • Our Team
  • Our Products
  • Careers
  • Investor Information
  • Company/Investor Presentation
  • Press Releases
  • Request Info
  • Legal Information
  • Cautionary Note
  • Privacy Policy
  • Contact
Xphyto test tubes in laboratory footer
Copyright © 2022 XPhyto Therapeutics Corporation
This website uses cookies and third party services. By clicking “Accept”, you consent to the use of all cookies
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT